PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 20, 2024ESMO OpenOpen Access

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial

View Full Paper
Ask AI
Bookmark
Share

Authors

TPThomas PowlesMBMauricio BurottoBEBernard Escudier

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Powles et al. (2024) studied this question.

synapsesocial.com/papers/68e6e3f4b6db64358765fea8https://doi.org/10.1016/j.esmoop.2024.102994
View Full Paper
Ask AI
Bookmark
Share